Method for treating corneal endothelial wounds
US5310728A · kind A · utility
6Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1992 |
| Grant date | May 10, 1994 |
| Priority date | — |
| Expiry date | Jul 23, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/414
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating corneal endothelial wounds comprises administering TGF-.alpha. to the region of the wound in an amount sufficient to promote the healing of endothelial cells. TGF-.alpha. advantageously is administered into the anterior chamber during ophthalmic surgical procedures, such as during intra-ocular lens implantation. The TGF-.alpha. preferably is administered as an active ingredient in an ophthalmological viscoelastic composition which improves the residence time of the growth factor in the anterior chamber.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.